Psychedelic mushroom producer First Person sets terms for $6M US IPO

February 10, 2023 · Seeking Alpha

Psychedelic mushroom producer First Person (FP) has set terms for a downsized $6M initial public offering.

First Person, which raises mushrooms for nutritional, nutraceutical and therapeutic purposes, said in a filing that it’s planning to offer 1M shares priced between $5.50 and $6.50, which should raise around $6M if priced at the midpoint.

Underwriters would be granted a 45-day option to buy up to a 150K additional shares to cover over-allotments. EF Hutton is serving as sole bookrunner. The company hopes to list its shares on Nasdaq under the symbol FP.

Selling shareholders are planning to offer 2.5M additional shares. The company would not see any proceeds from that sale.

In October, First Person said that it was planning to offer 1.1M shares priced between $6.75 and $7.75, which would have raised around $8M if priced at the midpoint at $7.25 per share.

Based in Calgary, Canada, First Person produces mushrooms for nutritional and nutraceutical purposes. The company also raises and researches mushrooms containing the psychedelic compound psilocybin.

In November, Canadian psychedelic drug developer Clearmind (CMNDuplisted its shares to Nasdaq and raised $8M. (Full Story)

Next Post

Can psychedelics really treat OCD, depression, and chronic pain? A researcher explains how they work and their potential risks

New research is exploring whether psychedelic drugs, taken under strict medical supervision, might help in treating post-traumatic stress disorder, chronic pain, depression and obsessive-compulsive disorder. SciLine interviewed Dr. Jennifer Mitchell—a professor in the Departments of Neurology and Psychiatry & Behavioral Science…
Read
Previous Post

First NYS adult-use cannabis dispensary in Upstate NY, Southern Tier opens for business

BINGHAMTON, N.Y. — The first adult-use cannabis dispensary north of New York City opened for business Friday on Court Street in Binghamton. It's no short drive for Western New Yorkers, at seven hours round-trip, but it is half the distance…
Read
Random Post

Across The Globe: Psychedelic Trials To Treat Late-Stage Cancer, Alzheimer's Begin

Core One Labs' Akome Partners To Study Next-Gen Psychedelics A subsidiary of Core One Labs  CLABF has signed a contract with Fundació Bosh I Gimpera to begin second-phase studies evaluating the therapeutic potential of its bio-compounds (both alone and combined with psychedelic substances). The…
Read
Random Post

Florida Marijuana Legalization Campaign Nears Signature Total Needed For Ballot Access

An industry-backed marijuana reform campaign has so far collected more than 70 percent of the signatures it needs to put a legalization initiative before voters on the 2024 ballot. The Florida Division of Elections updates petition counts on the measure…
Read
Random Post

Opinion: 5 steps to close the marijuana industry’s C-suite gender gap

In an industry that once had an unusually high percentage of female CEOs, the marijuana sector now has fewer women in leadership positions than the U.S. average. According to MJBizDaily’s 2022 report, “Diversity, Equity & Inclusion in the Cannabis Industry,” the percentage of women…
Read
Random Post

Jesse Ventura Considering Launching Cannabis Brand in Minnesota

During a cannabis expo in late July, former Minnesota Gov. Jesse Ventura said he is interested in launching a cannabis brand. Ventura, a former professional wrestler, actor, military veteran, and longtime cannabis advocate, said he wants “to be the first…
Read